Psyence Biomedical Ltd. (PBM) stock
Close on Oct 19, 2026Market cap –P/E –Yield –
Psyence Biomedical statistics
15 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Mar 31, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- 1688.1%
- 10.8%
GrowthIndustry
- EPS Growth (YoY)
- -138.3%
- -12.3%
EfficiencyIndustry
- Employee Count
- 12
- 74
Income statement (TTM)Industry
- Pretax Income
- -$6.23M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $7.19M
- $17.76M
- Net Cash Per Share
- $3.14
- $0.80
Cash flow (TTM)Industry
- Capital Expenditures
- -$229
- -$1.00M
- FCF Per Share
- -$3.55
- -$0.42
Taxes and interestIndustry
- Interest Expense
- $9.52K
- $2.90M
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | PBM | S&P 500 | Difference | PBM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -37.8% | +0.6% | −38.4 pts | ||
| 3 months | +34.2% | +3.4% | +30.8 pts | ||
| Year to date | +446.9% | +13.3% | +433.6 pts | ||
| 1 year | +17.0% | +16.6% | +0.4 pts | ||
| 3 years | -99.9% | +86.4% | −186.3 pts | -91.5% | +23.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M PBM shares were sold short on Oct 30, 2026, down 6.1% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 30.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 19,062 | -6.1% | 57,987 | 1.0 |
| Oct 15, 2026 | 20,292 | -24.4% | 48,093 | 1.0 |
| Sep 30, 2026 | 26,839 | -44.3% | 109,582 | 1.0 |
| Sep 15, 2026 | 48,219 | +245.6% | 66,626 | 1.0 |
| Aug 31, 2026 | 13,951 | -3.0% | 134,409 | 1.0 |
| Aug 14, 2026 | 14,380 | -61.6% | 42,408 | 1.0 |
| Jul 31, 2026 | 37,423 | +21.8% | 115,425 | 1.0 |
| Jul 15, 2026 | 30,720 | -14.7% | 65,112 | 1.0 |
| Jun 30, 2026 | 36,005 | +7.3% | 40,619 | 1.0 |
| Jun 15, 2026 | 33,547 | +29.1% | 101,481 | 1.0 |
| May 29, 2026 | 25,988 | -63.5% | 81,827 | 1.0 |
| May 15, 2026 | 71,272 | +71.1% | 232,272 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?